190 related articles for article (PubMed ID: 11684011)
21. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
Ripoll VM; Meadows NA; Raggatt LJ; Chang MK; Pettit AR; Cassady AI; Hume DA
Gene; 2008 Apr; 413(1-2):32-41. PubMed ID: 18313864
[TBL] [Abstract][Full Text] [Related]
22. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
Lee TH; Fevold KL; Muguruma Y; Lottsfeldt JL; Lee MY
Exp Hematol; 1994 Jan; 22(1):66-73. PubMed ID: 8282061
[TBL] [Abstract][Full Text] [Related]
23. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
24. TGF-β Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.
Asai K; Hisasue M; Shimokawa F; Funaba M; Murakami M
Biochem Genet; 2018 Oct; 56(5):542-552. PubMed ID: 29680988
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.
Niida S; Kaku M; Amano H; Yoshida H; Kataoka H; Nishikawa S; Tanne K; Maeda N; Nishikawa S; Kodama H
J Exp Med; 1999 Jul; 190(2):293-8. PubMed ID: 10432291
[TBL] [Abstract][Full Text] [Related]
26. Effect of a large deletion of the basic domain of mi transcription factor on differentiation of mast cells.
Morii E; Ogihara H; Oboki K; Kataoka TR; Maeyama K; Fisher DE; Lamoreux ML; Kitamura Y
Blood; 2001 Oct; 98(8):2577-9. PubMed ID: 11588059
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
28. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
29. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
30. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in the understanding of the pathophysiology of osteopetrosis.
Felix R; Hofstetter W; Cecchini MG
Eur J Endocrinol; 1996 Feb; 134(2):143-56. PubMed ID: 8630510
[TBL] [Abstract][Full Text] [Related]
32. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
33. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
34. Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation.
Lee K; Chung YH; Ahn H; Kim H; Rho J; Jeong D
Int J Biol Sci; 2016; 12(2):235-45. PubMed ID: 26884720
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
36. Blockade of CD26 signaling inhibits human osteoclast development.
Nishida H; Suzuki H; Madokoro H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
J Bone Miner Res; 2014 Nov; 29(11):2439-55. PubMed ID: 24821427
[TBL] [Abstract][Full Text] [Related]
37. Participation of protein kinase C beta in osteoclast differentiation and function.
Lee SW; Kwak HB; Chung WJ; Cheong H; Kim HH; Lee ZH
Bone; 2003 Mar; 32(3):217-27. PubMed ID: 12667549
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
39. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.
Srivastava S; Weitzmann MN; Kimble RB; Rizzo M; Zahner M; Milbrandt J; Ross FP; Pacifici R
J Clin Invest; 1998 Nov; 102(10):1850-9. PubMed ID: 9819371
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of protein kinases and Smad2 signaling pathways on osteoclast differentiation enhanced by activin A.
Murase Y; Okahashi N; Koseki T; Itoh K; Udagawa N; Hashimoto O; Sugino H; Noguchi T; Nishihara T
J Cell Physiol; 2001 Aug; 188(2):236-42. PubMed ID: 11424090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]